$5.72 Billion is the total value of Candriam S.C.A.'s 723 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
INTEL CORPsdcv 2.950%12/1 | $6,375,000 | +9.4% | 4,454 | 0.0% | 0.11% | +1.8% | ||
NUANCE COMMUNICATIONS INCnote 2.750%11/0 | $6,086,000 | +0.6% | 6,000 | 0.0% | 0.11% | -7.0% | ||
TTEK | TETRA TECH INC NEW | $5,958,000 | +1.7% | 128,000 | 0.0% | 0.10% | -5.5% | |
HOLOGIC INCfrnt 12/1 | $5,024,000 | -4.1% | 4,150 | 0.0% | 0.09% | -10.2% | ||
IMGN | IMMUNOGEN INC | $4,361,000 | +7.6% | 570,000 | 0.0% | 0.08% | 0.0% | |
ARES CAP CORPnote 4.750% 1/1 | $4,065,000 | -2.0% | 4,000 | 0.0% | 0.07% | -9.0% | ||
LXRX | LEXICON PHARMACEUTICALS INC | $3,601,000 | -25.3% | 293,000 | 0.0% | 0.06% | -30.8% | |
GHDX | GENOMIC HEALTH INC | $3,177,000 | -1.4% | 99,000 | 0.0% | 0.06% | -8.2% | |
ROVI CORPnote 0.500% 3/0 | $3,205,000 | +0.9% | 3,200 | 0.0% | 0.06% | -6.7% | ||
RARE | ULTRAGENYX PHARMACEUTICAL IN | $3,196,000 | -14.2% | 60,000 | 0.0% | 0.06% | -20.0% | |
PKI | PERKINELMER INC | $2,897,000 | +1.2% | 42,000 | 0.0% | 0.05% | -5.6% | |
ODP | OFFICE DEPOT INC | $2,809,000 | -19.5% | 618,721 | 0.0% | 0.05% | -25.8% | |
TGTX | TG THERAPEUTICS INC | $2,607,000 | +17.9% | 220,000 | 0.0% | 0.05% | +9.5% | |
CHRS | COHERUS BIOSCIENCES INC | $2,577,000 | -7.0% | 193,000 | 0.0% | 0.04% | -13.5% | |
CMS | CMS ENERGY CORP | $2,144,000 | +0.1% | 46,292 | 0.0% | 0.04% | -7.5% | |
ALRN | AILERON THERAPEUTICS INC | $2,007,000 | +20.0% | 150,000 | 0.0% | 0.04% | +12.9% | |
PCRX | PACIRA PHARMACEUTICALS INC | $1,990,000 | -21.3% | 53,000 | 0.0% | 0.04% | -27.1% | |
SPIRIT RLTY CAP INC NEWnote 2.875% 5/1 | $2,026,000 | +1.7% | 2,000 | 0.0% | 0.04% | -5.4% | ||
DVA | DAVITA INC | $1,663,000 | -8.3% | 28,000 | 0.0% | 0.03% | -14.7% | |
ALDR | ALDER BIOPHARMACEUTICALS INC | $1,433,000 | +6.9% | 117,000 | 0.0% | 0.02% | 0.0% | |
STAA | STAAR SURGICAL CO | $1,407,000 | +15.3% | 113,000 | 0.0% | 0.02% | +8.7% | |
CPRX | CATALYST PHARMACEUTICALS INC | $1,411,000 | -8.7% | 560,000 | 0.0% | 0.02% | -13.8% | |
REPH | RECRO PHARMA INC | $1,347,000 | +27.7% | 150,000 | 0.0% | 0.02% | +20.0% | |
WCN | WASTE CONNECTIONS INC | $1,328,000 | +8.6% | 18,984 | 0.0% | 0.02% | 0.0% | |
MKL | MARKEL CORP | $1,213,000 | +9.4% | 1,136 | 0.0% | 0.02% | 0.0% | |
AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $1,166,000 | -4.7% | 111,000 | 0.0% | 0.02% | -13.0% | |
LPL | LG DISPLAY CO LTDspons adr rep | $1,074,000 | -16.5% | 80,000 | 0.0% | 0.02% | -20.8% | |
EMN | EASTMAN CHEM CO | $1,116,000 | +7.7% | 12,329 | 0.0% | 0.02% | 0.0% | |
FRT | FEDERAL REALTY INVT TRsh ben int new | $1,074,000 | -1.7% | 8,648 | 0.0% | 0.02% | -9.5% | |
TAP | MOLSON COORS BREWING COcl b | $1,045,000 | -5.5% | 12,804 | 0.0% | 0.02% | -14.3% | |
ELGX | ENDOLOGIX INC | $981,000 | -8.2% | 220,000 | 0.0% | 0.02% | -15.0% | |
COG | CABOT OIL & GAS CORP | $908,000 | +6.6% | 33,960 | 0.0% | 0.02% | 0.0% | |
MLM | MARTIN MARIETTA MATLS INC | $915,000 | -7.4% | 4,438 | 0.0% | 0.02% | -15.8% | |
FLT | FLEETCOR TECHNOLOGIES INC | $844,000 | +7.2% | 5,454 | 0.0% | 0.02% | 0.0% | |
VTVT | VTV THERAPEUTICS INCcl a | $837,000 | +20.3% | 140,000 | 0.0% | 0.02% | +15.4% | |
FNF | FIDELITY NATIONAL FINANCIAL | $819,000 | +5.8% | 17,258 | 0.0% | 0.01% | -6.7% | |
ADS | ALLIANCE DATA SYSTEMS CORP | $797,000 | -13.7% | 3,596 | 0.0% | 0.01% | -17.6% | |
RDHL | REDHILL BIOPHARMA LTDsponsored ads | $770,000 | +24.4% | 71,267 | 0.0% | 0.01% | +8.3% | |
AUPH | AURINIA PHARMACEUTICALS INC | $740,000 | +2.4% | 118,000 | 0.0% | 0.01% | -7.1% | |
LB | L BRANDS INC | $741,000 | -22.7% | 17,802 | 0.0% | 0.01% | -27.8% | |
PHM | PULTE GROUP INC | $726,000 | +11.5% | 26,552 | 0.0% | 0.01% | +8.3% | |
CAJ | CANON INCsponsored adr | $700,000 | +0.9% | 20,400 | 0.0% | 0.01% | -7.7% | |
HRL | HORMEL FOODS CORP | $612,000 | -5.7% | 19,034 | 0.0% | 0.01% | -8.3% | |
TWTR | TWITTER INC | $605,000 | -5.6% | 35,887 | 0.0% | 0.01% | -8.3% | |
ATO | ATMOS ENERGY CORP | $578,000 | +1.0% | 6,896 | 0.0% | 0.01% | -9.1% | |
TRILLIUM THERAPEUTICS INC | $559,000 | +17.4% | 110,000 | 0.0% | 0.01% | +11.1% | ||
AYI | ACUITY BRANDS INC | $561,000 | -15.8% | 3,278 | 0.0% | 0.01% | -23.1% | |
CMG | CHIPOTLE MEXICAN GRILL INC | $511,000 | -25.9% | 1,659 | 0.0% | 0.01% | -30.8% | |
LW | LAMB WESTON HLDGS INC | $512,000 | +6.4% | 10,927 | 0.0% | 0.01% | 0.0% | |
EVHC | ENVISION HEALTHCARE CORP | $405,000 | -28.2% | 9,001 | 0.0% | 0.01% | -36.4% | |
SLG | SL GREEN RLTY CORP | $275,000 | -4.2% | 2,712 | 0.0% | 0.01% | 0.0% | |
ETFC | E TRADE FINANCIAL CORP | $259,000 | +14.6% | 5,936 | 0.0% | 0.01% | +25.0% | |
DISCA | DISCOVERY COMMUNICATNS NEW | $293,000 | -17.5% | 13,745 | 0.0% | 0.01% | -28.6% | |
NI | NISOURCE INC | $227,000 | +0.9% | 8,876 | 0.0% | 0.00% | 0.0% | |
TSN | TYSON FOODS INCcl a | $247,000 | +12.8% | 3,500 | 0.0% | 0.00% | 0.0% | |
PTI | PROTEOSTASIS THERAPEUTICS IN | $158,000 | -55.0% | 75,000 | 0.0% | 0.00% | -57.1% | |
GORO | GOLD RESOURCE CORP | $37,000 | -9.8% | 10,000 | 0.0% | 0.00% | 0.0% | |
SDRL | SEADRILL LIMITED | $5,000 | 0.0% | 13,100 | 0.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-03
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MICROSOFT CORP | 36 | Q3 2023 | 5.9% |
GILEAD SCIENCES INC | 36 | Q3 2023 | 3.1% |
MERCK & CO INC NEW | 36 | Q3 2023 | 2.6% |
REGENERON PHARMACEUTICALS | 36 | Q3 2023 | 2.0% |
JOHNSON & JOHNSON | 36 | Q3 2023 | 2.5% |
BIOGEN INC | 36 | Q3 2023 | 2.6% |
PROCTER & GAMBLE CO | 36 | Q3 2023 | 1.9% |
VERTEX PHARMACEUTICALS INC | 36 | Q3 2023 | 2.1% |
META PLATFORMS INC | 36 | Q3 2023 | 1.6% |
VISA INC | 36 | Q3 2023 | 1.2% |
View Candriam S.C.A.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-06 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-03 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-10 |
View Candriam S.C.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.